| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 32 | 2024 | 1782 | 3.010 |
Why?
|
| Prostatic Neoplasms | 57 | 2024 | 11083 | 2.790 |
Why?
|
| Laparoscopy | 19 | 2024 | 2039 | 2.510 |
Why?
|
| Prostate | 21 | 2024 | 1755 | 2.280 |
Why?
|
| Intermediate Filament Proteins | 59 | 1994 | 261 | 2.090 |
Why?
|
| Ultrasonography, Interventional | 5 | 2021 | 1531 | 1.370 |
Why?
|
| Urinary Bladder Neoplasms | 11 | 2024 | 2176 | 1.310 |
Why?
|
| Cystectomy | 8 | 2024 | 604 | 1.160 |
Why?
|
| Ureteral Obstruction | 3 | 2024 | 291 | 0.990 |
Why?
|
| Neuroglia | 52 | 1992 | 964 | 0.880 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2024 | 3181 | 0.880 |
Why?
|
| Spinal Cord | 39 | 1992 | 1784 | 0.880 |
Why?
|
| Glial Fibrillary Acidic Protein | 51 | 1992 | 564 | 0.830 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 2 | 2021 | 193 | 0.780 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4274 | 0.750 |
Why?
|
| Astrocytes | 38 | 1992 | 1345 | 0.680 |
Why?
|
| Neurofilament Proteins | 45 | 1995 | 337 | 0.670 |
Why?
|
| Surgical Mesh | 3 | 2009 | 315 | 0.670 |
Why?
|
| Cytoskeleton | 29 | 1990 | 1178 | 0.630 |
Why?
|
| Nerve Tissue Proteins | 63 | 1995 | 4392 | 0.630 |
Why?
|
| Kidney Pelvis | 3 | 2024 | 190 | 0.620 |
Why?
|
| Brain Chemistry | 19 | 1993 | 952 | 0.550 |
Why?
|
| Office Visits | 1 | 2021 | 595 | 0.540 |
Why?
|
| Fluorescent Antibody Technique | 79 | 1993 | 2476 | 0.540 |
Why?
|
| Robotics | 1 | 2023 | 809 | 0.530 |
Why?
|
| Paclitaxel | 3 | 2023 | 1728 | 0.530 |
Why?
|
| Neurofibrils | 14 | 1984 | 75 | 0.530 |
Why?
|
| Intermediate Filaments | 14 | 1994 | 171 | 0.520 |
Why?
|
| Watchful Waiting | 4 | 2023 | 493 | 0.520 |
Why?
|
| Kidney | 9 | 2023 | 7066 | 0.520 |
Why?
|
| Hernia, Inguinal | 3 | 2009 | 224 | 0.470 |
Why?
|
| Prostate-Specific Antigen | 13 | 2024 | 2464 | 0.440 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2023 | 790 | 0.420 |
Why?
|
| Axons | 21 | 1992 | 1682 | 0.410 |
Why?
|
| Ganglia, Spinal | 10 | 1992 | 529 | 0.390 |
Why?
|
| Rats, Inbred Strains | 40 | 1992 | 2077 | 0.380 |
Why?
|
| Wallerian Degeneration | 10 | 1993 | 68 | 0.370 |
Why?
|
| Neoplasm Invasiveness | 9 | 2024 | 3602 | 0.370 |
Why?
|
| Male | 116 | 2024 | 363691 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2024 | 9373 | 0.370 |
Why?
|
| Nerve Regeneration | 11 | 1993 | 802 | 0.350 |
Why?
|
| Rats | 103 | 1994 | 23707 | 0.340 |
Why?
|
| Retrospective Studies | 32 | 2024 | 81515 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 36532 | 0.340 |
Why?
|
| Sciatic Nerve | 11 | 1993 | 628 | 0.330 |
Why?
|
| Chyle | 1 | 2009 | 17 | 0.330 |
Why?
|
| Biopsy | 11 | 2023 | 6763 | 0.320 |
Why?
|
| Pheochromocytoma | 2 | 2011 | 323 | 0.320 |
Why?
|
| Laminin | 12 | 1993 | 404 | 0.310 |
Why?
|
| Adrenalectomy | 1 | 2011 | 344 | 0.310 |
Why?
|
| Nerve Degeneration | 11 | 1990 | 748 | 0.310 |
Why?
|
| Adenocarcinoma | 9 | 2021 | 6364 | 0.310 |
Why?
|
| Middle Aged | 64 | 2024 | 223004 | 0.300 |
Why?
|
| Desmin | 7 | 1989 | 100 | 0.290 |
Why?
|
| Neoplasm Staging | 11 | 2024 | 11206 | 0.290 |
Why?
|
| Humans | 141 | 2024 | 765956 | 0.290 |
Why?
|
| Fistula | 1 | 2009 | 212 | 0.280 |
Why?
|
| Optic Nerve | 14 | 1992 | 567 | 0.270 |
Why?
|
| Nephrectomy | 5 | 2024 | 927 | 0.270 |
Why?
|
| Aged | 51 | 2024 | 171114 | 0.270 |
Why?
|
| Cerebellum | 20 | 1990 | 1518 | 0.270 |
Why?
|
| Molecular Weight | 28 | 1989 | 2163 | 0.260 |
Why?
|
| Carrier Proteins | 12 | 1993 | 4913 | 0.260 |
Why?
|
| Peripheral Nerves | 7 | 2020 | 491 | 0.250 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2011 | 730 | 0.250 |
Why?
|
| Epitopes | 16 | 1992 | 2523 | 0.250 |
Why?
|
| Muscles | 5 | 2023 | 1578 | 0.250 |
Why?
|
| BCG Vaccine | 2 | 2024 | 380 | 0.250 |
Why?
|
| Hyaluronic Acid | 4 | 1993 | 484 | 0.250 |
Why?
|
| Testis | 2 | 2018 | 780 | 0.240 |
Why?
|
| Hematuria | 2 | 2011 | 230 | 0.230 |
Why?
|
| Urologic Surgical Procedures | 2 | 2024 | 281 | 0.230 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2018 | 950 | 0.220 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3236 | 0.210 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 1993 | 142 | 0.210 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2004 | 186 | 0.210 |
Why?
|
| Kidney Transplantation | 2 | 2009 | 4270 | 0.210 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2024 | 347 | 0.200 |
Why?
|
| Treatment Outcome | 19 | 2024 | 65189 | 0.200 |
Why?
|
| Neurons | 25 | 2008 | 9524 | 0.200 |
Why?
|
| Autonomic Nervous System | 4 | 2024 | 706 | 0.200 |
Why?
|
| Cattle | 30 | 1987 | 3801 | 0.190 |
Why?
|
| Central Nervous System | 6 | 1987 | 1341 | 0.190 |
Why?
|
| Kidney Diseases | 2 | 2010 | 2098 | 0.190 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2022 | 76 | 0.190 |
Why?
|
| Vimentin | 15 | 1989 | 258 | 0.190 |
Why?
|
| Tuberculosis, Male Genital | 2 | 2018 | 6 | 0.190 |
Why?
|
| Brain | 39 | 1995 | 27178 | 0.180 |
Why?
|
| Diagnostic Imaging | 4 | 2015 | 3529 | 0.180 |
Why?
|
| Muscle Proteins | 8 | 1982 | 1158 | 0.180 |
Why?
|
| Urinary Bladder | 4 | 2023 | 1154 | 0.180 |
Why?
|
| Animals | 159 | 2015 | 168759 | 0.180 |
Why?
|
| Neurons, Afferent | 6 | 1994 | 497 | 0.180 |
Why?
|
| Immune Sera | 15 | 1984 | 601 | 0.170 |
Why?
|
| Kidney Calculi | 1 | 2004 | 457 | 0.170 |
Why?
|
| Brachytherapy | 2 | 2022 | 1222 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 23 | 1992 | 9249 | 0.170 |
Why?
|
| Perineum | 1 | 2021 | 213 | 0.170 |
Why?
|
| Peritoneum | 1 | 2021 | 224 | 0.170 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2019 | 42 | 0.170 |
Why?
|
| Prognosis | 13 | 2024 | 29921 | 0.160 |
Why?
|
| Retina | 10 | 1991 | 2657 | 0.160 |
Why?
|
| Nerve Tissue | 3 | 1991 | 78 | 0.160 |
Why?
|
| Motor Neurons | 8 | 1994 | 869 | 0.160 |
Why?
|
| Spermatocele | 1 | 2018 | 10 | 0.160 |
Why?
|
| Kallikreins | 1 | 2020 | 220 | 0.160 |
Why?
|
| Urethra | 4 | 2022 | 406 | 0.150 |
Why?
|
| Antibody Specificity | 5 | 1987 | 1061 | 0.150 |
Why?
|
| Varicocele | 1 | 2018 | 75 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 15 | 1990 | 1701 | 0.150 |
Why?
|
| Epididymitis | 1 | 2018 | 37 | 0.150 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 521 | 0.150 |
Why?
|
| Orchitis | 1 | 2018 | 36 | 0.150 |
Why?
|
| Receptors, Androgen | 4 | 2018 | 1088 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 19 | 1987 | 1724 | 0.150 |
Why?
|
| Adult | 29 | 2024 | 223038 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 8529 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 2 | 2024 | 936 | 0.140 |
Why?
|
| Diagnosis, Differential | 9 | 2022 | 12976 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2021 | 6499 | 0.140 |
Why?
|
| Cisplatin | 1 | 2023 | 1658 | 0.140 |
Why?
|
| Incidental Findings | 2 | 2019 | 697 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1273 | 0.140 |
Why?
|
| Oxides | 2 | 2009 | 402 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11868 | 0.130 |
Why?
|
| Goldfish | 3 | 1992 | 65 | 0.130 |
Why?
|
| Medical Oncology | 1 | 2008 | 2339 | 0.130 |
Why?
|
| Androstenes | 1 | 2018 | 178 | 0.130 |
Why?
|
| Nerve Fibers | 8 | 1994 | 705 | 0.130 |
Why?
|
| Histocytochemistry | 16 | 1987 | 696 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2021 | 1339 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 1993 | 1727 | 0.130 |
Why?
|
| Kuru | 2 | 1985 | 4 | 0.130 |
Why?
|
| Penile Diseases | 1 | 1996 | 47 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 717 | 0.120 |
Why?
|
| Ureter | 2 | 2004 | 364 | 0.120 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 123 | 0.120 |
Why?
|
| Chickens | 11 | 1987 | 842 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 745 | 0.120 |
Why?
|
| Immunohistochemistry | 21 | 2022 | 11022 | 0.120 |
Why?
|
| Disease-Free Survival | 7 | 2024 | 6832 | 0.120 |
Why?
|
| Lampreys | 2 | 1992 | 32 | 0.120 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 2 | 1985 | 92 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15747 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39194 | 0.110 |
Why?
|
| Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.110 |
Why?
|
| Animals, Newborn | 9 | 1993 | 2669 | 0.110 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2014 | 34 | 0.110 |
Why?
|
| Myelin Sheath | 3 | 1992 | 652 | 0.110 |
Why?
|
| Dendrites | 4 | 1986 | 469 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 206 | 0.110 |
Why?
|
| Time Factors | 19 | 2020 | 40065 | 0.110 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 59488 | 0.110 |
Why?
|
| Urinary Diversion | 1 | 2014 | 134 | 0.110 |
Why?
|
| Gliosis | 7 | 1991 | 247 | 0.110 |
Why?
|
| Ultrasonography | 4 | 2018 | 5993 | 0.110 |
Why?
|
| Lizards | 2 | 1990 | 50 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1394 | 0.100 |
Why?
|
| Afferent Pathways | 2 | 1991 | 303 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1749 | 0.100 |
Why?
|
| Survival Rate | 6 | 2019 | 12795 | 0.100 |
Why?
|
| Immunodiffusion | 12 | 1980 | 140 | 0.100 |
Why?
|
| Acrylamides | 2 | 1991 | 257 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 664 | 0.100 |
Why?
|
| Digestive System | 2 | 1991 | 244 | 0.100 |
Why?
|
| Purkinje Cells | 5 | 1987 | 228 | 0.100 |
Why?
|
| Cystoscopy | 2 | 2009 | 128 | 0.100 |
Why?
|
| Iris | 4 | 1985 | 232 | 0.100 |
Why?
|
| Female | 51 | 2024 | 396101 | 0.090 |
Why?
|
| Prospective Studies | 8 | 2024 | 54806 | 0.090 |
Why?
|
| Spiral Ganglion | 3 | 1994 | 180 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2015 | 722 | 0.090 |
Why?
|
| Cohort Studies | 7 | 2023 | 41647 | 0.090 |
Why?
|
| Radiation Injuries | 2 | 2016 | 1181 | 0.090 |
Why?
|
| Urethral Neoplasms | 1 | 2011 | 37 | 0.090 |
Why?
|
| Hippocampus | 7 | 1990 | 3775 | 0.090 |
Why?
|
| Aluminum | 3 | 1982 | 150 | 0.090 |
Why?
|
| Rabbits | 17 | 1990 | 4734 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2021 | 24283 | 0.090 |
Why?
|
| Carcinoma | 2 | 2017 | 2312 | 0.090 |
Why?
|
| Phosphorylation | 12 | 1995 | 8278 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2010 | 34 | 0.090 |
Why?
|
| Lymphangiectasis | 1 | 2010 | 20 | 0.090 |
Why?
|
| Microscopy, Electron | 12 | 1993 | 2548 | 0.090 |
Why?
|
| Retroperitoneal Space | 1 | 2011 | 173 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 2016 | 1203 | 0.080 |
Why?
|
| Iron | 2 | 2009 | 1816 | 0.080 |
Why?
|
| Lymphatic Metastasis | 4 | 2011 | 2887 | 0.080 |
Why?
|
| Nervous System Diseases | 2 | 1994 | 1660 | 0.080 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3946 | 0.080 |
Why?
|
| Polycythemia | 1 | 2010 | 125 | 0.080 |
Why?
|
| Risk Factors | 13 | 2024 | 74836 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 833 | 0.080 |
Why?
|
| Diaphragm | 1 | 1991 | 356 | 0.080 |
Why?
|
| Spinal Nerve Roots | 1 | 1989 | 122 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1990 | 345 | 0.080 |
Why?
|
| Embryo, Mammalian | 3 | 1992 | 1673 | 0.080 |
Why?
|
| Androgen Antagonists | 2 | 2015 | 1411 | 0.080 |
Why?
|
| Fishes | 4 | 1986 | 606 | 0.080 |
Why?
|
| Antibodies | 12 | 1990 | 2417 | 0.080 |
Why?
|
| Salvage Therapy | 3 | 2024 | 1272 | 0.080 |
Why?
|
| Species Specificity | 9 | 1992 | 2406 | 0.080 |
Why?
|
| Disease Progression | 3 | 2023 | 13631 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2709 | 0.070 |
Why?
|
| Cerebral Cortex | 11 | 1988 | 5767 | 0.070 |
Why?
|
| Schwann Cells | 3 | 1985 | 195 | 0.070 |
Why?
|
| Urography | 1 | 2009 | 316 | 0.070 |
Why?
|
| Aging | 7 | 1990 | 8731 | 0.070 |
Why?
|
| Paraproteinemias | 1 | 2010 | 252 | 0.070 |
Why?
|
| Peptides | 7 | 1982 | 4331 | 0.070 |
Why?
|
| Lymphatic Diseases | 1 | 2009 | 317 | 0.070 |
Why?
|
| Time Management | 1 | 2007 | 53 | 0.070 |
Why?
|
| Cyanogen Bromide | 4 | 1984 | 75 | 0.070 |
Why?
|
| Olfactory Nerve | 1 | 1987 | 21 | 0.070 |
Why?
|
| Chick Embryo | 5 | 1992 | 964 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2005 | 13039 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 1917 | 0.070 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 540 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2021 | 3690 | 0.070 |
Why?
|
| Bronchi | 1 | 1991 | 843 | 0.070 |
Why?
|
| Immunochemistry | 8 | 1988 | 116 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2024 | 2652 | 0.070 |
Why?
|
| Trinucleotide Repeats | 2 | 1998 | 258 | 0.070 |
Why?
|
| Bucladesine | 2 | 1990 | 117 | 0.070 |
Why?
|
| Preoperative Care | 3 | 2015 | 2267 | 0.070 |
Why?
|
| Cells, Cultured | 24 | 1992 | 18973 | 0.060 |
Why?
|
| Fibronectins | 6 | 1992 | 719 | 0.060 |
Why?
|
| Scrapie | 1 | 1985 | 20 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2011 | 906 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1511 | 0.060 |
Why?
|
| Astrocytoma | 3 | 1989 | 772 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 1986 | 104 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1990 | 896 | 0.060 |
Why?
|
| Urinary Fistula | 1 | 2005 | 44 | 0.060 |
Why?
|
| Cartilage | 1 | 1989 | 798 | 0.060 |
Why?
|
| Ileus | 1 | 2005 | 65 | 0.060 |
Why?
|
| Nervous System | 2 | 1986 | 542 | 0.060 |
Why?
|
| Trachea | 1 | 1991 | 1085 | 0.060 |
Why?
|
| Flank Pain | 1 | 2004 | 44 | 0.060 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1986 | 156 | 0.060 |
Why?
|
| Mesencephalon | 1 | 1986 | 338 | 0.060 |
Why?
|
| Obesity | 2 | 2012 | 13075 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2005 | 508 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 1986 | 420 | 0.050 |
Why?
|
| Versicans | 2 | 1993 | 40 | 0.050 |
Why?
|
| Ganglia, Sympathetic | 3 | 1990 | 63 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2014 | 1940 | 0.050 |
Why?
|
| Cell Aggregation | 4 | 1979 | 238 | 0.050 |
Why?
|
| Rectum | 1 | 2008 | 896 | 0.050 |
Why?
|
| Locus Coeruleus | 2 | 1984 | 239 | 0.050 |
Why?
|
| Polylysine | 3 | 1992 | 130 | 0.050 |
Why?
|
| Neuroblastoma | 2 | 1984 | 1263 | 0.050 |
Why?
|
| Staining and Labeling | 4 | 1991 | 1072 | 0.050 |
Why?
|
| Cell Differentiation | 16 | 1990 | 11640 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9524 | 0.050 |
Why?
|
| Autoantibodies | 3 | 1986 | 2113 | 0.050 |
Why?
|
| Tubulin | 6 | 1991 | 692 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 1988 | 2446 | 0.050 |
Why?
|
| Immunoelectrophoresis | 6 | 1977 | 94 | 0.050 |
Why?
|
| Dogs | 6 | 1990 | 3822 | 0.050 |
Why?
|
| Vinblastine | 3 | 1980 | 483 | 0.050 |
Why?
|
| Tissue Distribution | 5 | 1990 | 2266 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2005 | 437 | 0.050 |
Why?
|
| Synapses | 2 | 1990 | 1754 | 0.050 |
Why?
|
| Colchicine | 2 | 1980 | 256 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3620 | 0.050 |
Why?
|
| Age Factors | 6 | 2020 | 18380 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2021 | 124 | 0.050 |
Why?
|
| Culture Techniques | 3 | 1989 | 515 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2007 | 788 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 15398 | 0.040 |
Why?
|
| Edema | 2 | 2018 | 760 | 0.040 |
Why?
|
| Mitosis | 1 | 1986 | 1173 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1984 | 289 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2005 | 491 | 0.040 |
Why?
|
| Boston | 3 | 2019 | 9338 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5337 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 1981 | 212 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1994 | 238 | 0.040 |
Why?
|
| Head-Down Tilt | 1 | 2019 | 67 | 0.040 |
Why?
|
| Nitriles | 2 | 2015 | 982 | 0.040 |
Why?
|
| Multiple Sclerosis | 6 | 1989 | 3213 | 0.040 |
Why?
|
| Capsaicin | 2 | 1991 | 226 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2005 | 786 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1986 | 1499 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 567 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2966 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 2567 | 0.040 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 931 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2005 | 1259 | 0.040 |
Why?
|
| Polymorphism, Genetic | 3 | 1998 | 4247 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2536 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2858 | 0.040 |
Why?
|
| Cytoplasm | 2 | 1994 | 1500 | 0.040 |
Why?
|
| Amyloid | 1 | 1984 | 853 | 0.040 |
Why?
|
| Chromatography, Affinity | 5 | 1984 | 521 | 0.040 |
Why?
|
| Glioma | 7 | 1989 | 3493 | 0.040 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2019 | 135 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1983 | 518 | 0.040 |
Why?
|
| HIV-1 | 1 | 1996 | 6944 | 0.040 |
Why?
|
| Anterior Chamber | 2 | 1989 | 194 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2024 | 1329 | 0.040 |
Why?
|
| Contrast Media | 2 | 2009 | 5329 | 0.040 |
Why?
|
| Wounds, Penetrating | 2 | 1990 | 317 | 0.040 |
Why?
|
| Mice | 24 | 2015 | 81818 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1106 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1986 | 2002 | 0.040 |
Why?
|
| Dopamine | 2 | 1986 | 1582 | 0.040 |
Why?
|
| Alzheimer Disease | 3 | 1985 | 8728 | 0.040 |
Why?
|
| Brain Stem | 2 | 1981 | 853 | 0.040 |
Why?
|
| Testicular Diseases | 1 | 2018 | 72 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3454 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 1964 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1992 | 1957 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2004 | 762 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 2003 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 1985 | 4528 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2024 | 2720 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 2 | 2009 | 349 | 0.040 |
Why?
|
| Vincristine | 1 | 1980 | 1039 | 0.030 |
Why?
|
| Rats, Mutant Strains | 2 | 1989 | 59 | 0.030 |
Why?
|
| beta Catenin | 1 | 2022 | 1043 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2019 | 328 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 2 | 2009 | 309 | 0.030 |
Why?
|
| Keratins | 4 | 1986 | 498 | 0.030 |
Why?
|
| Immunoblotting | 2 | 1991 | 1644 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1977 | 123 | 0.030 |
Why?
|
| Myosins | 1 | 1978 | 408 | 0.030 |
Why?
|
| Cross Reactions | 6 | 1980 | 824 | 0.030 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 1997 | 75 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20660 | 0.030 |
Why?
|
| Dextrans | 2 | 2009 | 571 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1772 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1866 | 0.030 |
Why?
|
| Organ of Corti | 2 | 1994 | 85 | 0.030 |
Why?
|
| Dogfish | 2 | 1986 | 11 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 3 | 1985 | 127 | 0.030 |
Why?
|
| Trout | 2 | 1986 | 20 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1168 | 0.030 |
Why?
|
| Organ Culture Techniques | 2 | 1993 | 788 | 0.030 |
Why?
|
| Serotonin | 1 | 1981 | 1047 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2018 | 460 | 0.030 |
Why?
|
| Frontal Lobe | 2 | 1982 | 1409 | 0.030 |
Why?
|
| Eye Injuries | 1 | 1979 | 228 | 0.030 |
Why?
|
| Leukocyte Disorders | 1 | 2015 | 11 | 0.030 |
Why?
|
| Turtles | 3 | 1985 | 40 | 0.030 |
Why?
|
| Rats, Inbred F344 | 4 | 1986 | 822 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1555 | 0.030 |
Why?
|
| Proteins | 2 | 1981 | 5995 | 0.030 |
Why?
|
| Propensity Score | 1 | 2023 | 1968 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2021 | 2601 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3475 | 0.030 |
Why?
|
| Cyprinidae | 1 | 1974 | 35 | 0.030 |
Why?
|
| Mycobacterium | 1 | 1996 | 253 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1994 | 8102 | 0.030 |
Why?
|
| Evoked Potentials | 3 | 1990 | 1048 | 0.030 |
Why?
|
| Acrylamide | 2 | 1991 | 59 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1981 | 4159 | 0.030 |
Why?
|
| Incidence | 4 | 2017 | 21480 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 1995 | 212 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2018 | 22222 | 0.030 |
Why?
|
| Isoelectric Focusing | 3 | 1989 | 148 | 0.030 |
Why?
|
| Guinea Pigs | 8 | 1990 | 1300 | 0.030 |
Why?
|
| Cell Division | 4 | 1990 | 4475 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 141 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2108 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3343 | 0.030 |
Why?
|
| Brain Neoplasms | 5 | 1989 | 9071 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1981 | 2477 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1985 | 173 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 20125 | 0.030 |
Why?
|
| Heart Rate | 1 | 2024 | 4203 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1986 | 340 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 566 | 0.030 |
Why?
|
| Stents | 1 | 2004 | 3213 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1909 | 0.030 |
Why?
|
| Rats, Nude | 2 | 1989 | 105 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1167 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2017 | 802 | 0.020 |
Why?
|
| Rana pipiens | 2 | 1985 | 64 | 0.020 |
Why?
|
| Recurrence | 1 | 2004 | 8501 | 0.020 |
Why?
|
| Cerebellar Cortex | 1 | 1973 | 108 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 1986 | 3596 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6321 | 0.020 |
Why?
|
| Amino Acid Sequence | 5 | 1995 | 13400 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1990 | 1617 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 2 | 1989 | 812 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2796 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 1990 | 179 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 660 | 0.020 |
Why?
|
| Cell Movement | 3 | 1991 | 5194 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 1973 | 249 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 57 | 0.020 |
Why?
|
| Neuropeptides | 2 | 1994 | 951 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 903 | 0.020 |
Why?
|
| Axonal Transport | 2 | 1989 | 178 | 0.020 |
Why?
|
| Amino Acids | 5 | 1981 | 1709 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12509 | 0.020 |
Why?
|
| Neurites | 1 | 1992 | 389 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1993 | 793 | 0.020 |
Why?
|
| Ribs | 1 | 2012 | 254 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1990 | 398 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 1990 | 339 | 0.020 |
Why?
|
| Urinary Retention | 1 | 1991 | 100 | 0.020 |
Why?
|
| S100 Proteins | 3 | 1985 | 217 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3430 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1377 | 0.020 |
Why?
|
| Parietal Lobe | 2 | 1986 | 858 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 1993 | 592 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2015 | 10070 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1992 | 1391 | 0.020 |
Why?
|
| Pineal Gland | 1 | 1990 | 153 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 2010 | 274 | 0.020 |
Why?
|
| Ganglia | 2 | 1986 | 86 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 1986 | 5849 | 0.020 |
Why?
|
| Hexanones | 1 | 1988 | 5 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2428 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1990 | 1735 | 0.020 |
Why?
|
| Models, Biological | 1 | 2024 | 9443 | 0.020 |
Why?
|
| Fetus | 3 | 1994 | 1878 | 0.020 |
Why?
|
| Cochlea | 1 | 1994 | 847 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1978 | 0.020 |
Why?
|
| Sheep | 2 | 1985 | 1440 | 0.020 |
Why?
|
| HEPES | 1 | 1987 | 10 | 0.020 |
Why?
|
| Clone Cells | 2 | 1984 | 1672 | 0.020 |
Why?
|
| Trypsin | 2 | 1986 | 487 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2035 | 0.020 |
Why?
|
| Skull | 1 | 2012 | 811 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2015 | 2599 | 0.020 |
Why?
|
| Dementia | 2 | 1982 | 2744 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14652 | 0.020 |
Why?
|
| Choristoma | 1 | 1989 | 206 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1989 | 304 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3608 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2024 | 23600 | 0.020 |
Why?
|
| Ketones | 1 | 1988 | 183 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1986 | 59 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1987 | 152 | 0.020 |
Why?
|
| Eye | 1 | 1991 | 710 | 0.020 |
Why?
|
| Quinolinic Acids | 1 | 1986 | 15 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2261 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1987 | 139 | 0.020 |
Why?
|
| Trigeminal Nerve | 2 | 1985 | 253 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1974 | 928 | 0.020 |
Why?
|
| Cell Adhesion | 4 | 1989 | 3089 | 0.020 |
Why?
|
| Peptide Fragments | 4 | 1984 | 5125 | 0.020 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 1986 | 6 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1990 | 7851 | 0.020 |
Why?
|
| Mutation | 3 | 2024 | 30196 | 0.020 |
Why?
|
| Survivors | 1 | 2017 | 2372 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 533 | 0.020 |
Why?
|
| Bufonidae | 1 | 1985 | 12 | 0.020 |
Why?
|
| Electrophoresis, Disc | 2 | 1977 | 66 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13648 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1989 | 606 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1974 | 1546 | 0.020 |
Why?
|
| Azo Compounds | 1 | 1986 | 115 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2008 | 245 | 0.020 |
Why?
|
| Oligodendroglia | 3 | 1981 | 542 | 0.020 |
Why?
|
| Pancreatic Polypeptide | 1 | 1985 | 35 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1985 | 76 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 746 | 0.020 |
Why?
|
| Gestational Age | 4 | 1989 | 3613 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 712 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1985 | 224 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8611 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 8067 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 363 | 0.010 |
Why?
|
| Pyridines | 2 | 1986 | 2888 | 0.010 |
Why?
|
| Trigeminal Ganglion | 1 | 1985 | 189 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1993 | 2817 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1984 | 109 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2014 | 2590 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9649 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1990 | 1167 | 0.010 |
Why?
|
| Congo Red | 1 | 1984 | 49 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1986 | 939 | 0.010 |
Why?
|
| Swine | 3 | 1995 | 5988 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1986 | 416 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1984 | 204 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1989 | 2394 | 0.010 |
Why?
|
| tau Proteins | 1 | 1994 | 2112 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1987 | 743 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1984 | 642 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2008 | 8733 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12057 | 0.010 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 1983 | 9 | 0.010 |
Why?
|
| Glycoproteins | 2 | 1983 | 2195 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4520 | 0.010 |
Why?
|
| Ependymoma | 2 | 1983 | 310 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1985 | 387 | 0.010 |
Why?
|
| Carbonic Anhydrases | 1 | 1983 | 107 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1984 | 225 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1982 | 46 | 0.010 |
Why?
|
| Neutrophils | 1 | 2015 | 3776 | 0.010 |
Why?
|
| Tryptophan | 1 | 1984 | 483 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1986 | 698 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1984 | 337 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 508 | 0.010 |
Why?
|
| Anencephaly | 1 | 1981 | 20 | 0.010 |
Why?
|
| Epidermis | 1 | 1985 | 538 | 0.010 |
Why?
|
| Ileum | 1 | 1984 | 558 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1986 | 13451 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1986 | 811 | 0.010 |
Why?
|
| Pons | 1 | 1982 | 238 | 0.010 |
Why?
|
| Mesoderm | 1 | 1984 | 679 | 0.010 |
Why?
|
| Hair Cells, Auditory | 2 | 1994 | 383 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 1737 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1983 | 301 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 791 | 0.010 |
Why?
|
| Arteries | 1 | 1986 | 1118 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1986 | 952 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 480 | 0.010 |
Why?
|
| Nanostructures | 1 | 2005 | 548 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1986 | 1072 | 0.010 |
Why?
|
| Epithelium | 1 | 1985 | 1599 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1986 | 659 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1986 | 2627 | 0.010 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1980 | 20 | 0.010 |
Why?
|
| Chordoma | 1 | 1983 | 343 | 0.010 |
Why?
|
| Antigens | 2 | 1977 | 1438 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1175 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1983 | 335 | 0.010 |
Why?
|
| Mass Screening | 1 | 2015 | 5445 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1534 | 0.010 |
Why?
|
| Cysteine | 1 | 1984 | 898 | 0.010 |
Why?
|
| Spleen | 1 | 1986 | 2296 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1986 | 1214 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1981 | 380 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 6919 | 0.010 |
Why?
|
| Wakefulness | 1 | 1986 | 1282 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10563 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 17075 | 0.010 |
Why?
|
| Medulla Oblongata | 2 | 1978 | 246 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1983 | 1689 | 0.010 |
Why?
|
| Aorta | 1 | 1986 | 2028 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 1946 | 0.010 |
Why?
|
| Graft Survival | 1 | 1989 | 3890 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1987 | 6220 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 990 | 0.010 |
Why?
|
| Cell Line | 3 | 1980 | 15543 | 0.010 |
Why?
|
| Optic Nerve Injuries | 1 | 1979 | 150 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10383 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2001 | 629 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13266 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1985 | 3946 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1162 | 0.010 |
Why?
|
| Neuropeptide Y | 2 | 1990 | 194 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3672 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1998 | 254 | 0.010 |
Why?
|
| Piperazines | 1 | 1987 | 2549 | 0.010 |
Why?
|
| Pregnancy | 4 | 1992 | 30258 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 193 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72898 | 0.010 |
Why?
|
| Denervation | 2 | 1987 | 265 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4893 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1975 | 81 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1986 | 3087 | 0.010 |
Why?
|
| Maturation-Promoting Factor | 1 | 1995 | 26 | 0.010 |
Why?
|
| Dansyl Compounds | 1 | 1974 | 19 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 2120 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 1990 | 331 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 780 | 0.010 |
Why?
|
| Densitometry | 1 | 1974 | 150 | 0.010 |
Why?
|
| 4-Butyrolactone | 1 | 1995 | 60 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1984 | 5379 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 243 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1981 | 1270 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1994 | 115 | 0.010 |
Why?
|
| Colorimetry | 1 | 1974 | 148 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1995 | 110 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 629 | 0.010 |
Why?
|
| Phosphates | 1 | 1978 | 763 | 0.010 |
Why?
|
| Neurons, Efferent | 1 | 1994 | 81 | 0.010 |
Why?
|
| Anura | 1 | 1973 | 79 | 0.010 |
Why?
|
| Goats | 1 | 1974 | 166 | 0.010 |
Why?
|
| Seizures | 1 | 1987 | 3000 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 187 | 0.010 |
Why?
|
| Polyribosomes | 2 | 1984 | 109 | 0.010 |
Why?
|
| Phalloidine | 1 | 1993 | 21 | 0.010 |
Why?
|
| Microsomes | 2 | 1984 | 252 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1976 | 1430 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2159 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1986 | 2531 | 0.010 |
Why?
|
| Substantia Nigra | 2 | 1987 | 346 | 0.010 |
Why?
|
| Cats | 2 | 1985 | 972 | 0.010 |
Why?
|
| Cyclins | 1 | 1995 | 598 | 0.010 |
Why?
|
| Urea | 1 | 1974 | 448 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 1775 | 0.010 |
Why?
|
| Actins | 1 | 1979 | 2056 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1983 | 1484 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2001 | 2395 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6598 | 0.010 |
Why?
|
| Autopsy | 1 | 1974 | 1011 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1752 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1985 | 1965 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 6547 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5302 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1997 | 3624 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1990 | 137 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 17594 | 0.010 |
Why?
|
| Androgens | 1 | 1997 | 1279 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 704 | 0.000 |
Why?
|
| Polysaccharide-Lyases | 1 | 1989 | 48 | 0.000 |
Why?
|
| Microtubules | 1 | 1995 | 1062 | 0.000 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 283 | 0.000 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1990 | 365 | 0.000 |
Why?
|
| Corpus Striatum | 2 | 1986 | 1218 | 0.000 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1990 | 262 | 0.000 |
Why?
|
| Kinetics | 2 | 1989 | 6274 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1056 | 0.000 |
Why?
|
| Heparitin Sulfate | 1 | 1989 | 223 | 0.000 |
Why?
|
| Viscera | 1 | 1988 | 137 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6069 | 0.000 |
Why?
|
| Length of Stay | 1 | 2001 | 6485 | 0.000 |
Why?
|
| Nomifensine | 1 | 1986 | 14 | 0.000 |
Why?
|
| Cytarabine | 1 | 1989 | 698 | 0.000 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1986 | 88 | 0.000 |
Why?
|
| Quinolinic Acid | 1 | 1986 | 67 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1986 | 168 | 0.000 |
Why?
|
| Testosterone | 1 | 1997 | 2494 | 0.000 |
Why?
|
| Alleles | 1 | 1997 | 6897 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 212 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1987 | 248 | 0.000 |
Why?
|
| Microinjections | 1 | 1986 | 320 | 0.000 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1985 | 74 | 0.000 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1985 | 15 | 0.000 |
Why?
|
| Biogenic Amines | 1 | 1984 | 53 | 0.000 |
Why?
|
| Collagen | 1 | 1993 | 2618 | 0.000 |
Why?
|
| Myenteric Plexus | 1 | 1984 | 49 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3715 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1984 | 226 | 0.000 |
Why?
|
| Adrenal Medulla | 1 | 1983 | 54 | 0.000 |
Why?
|
| Paraffin | 1 | 1983 | 36 | 0.000 |
Why?
|
| Desmosomes | 1 | 1983 | 72 | 0.000 |
Why?
|
| Mesentery | 1 | 1984 | 199 | 0.000 |
Why?
|
| Monensin | 1 | 1983 | 30 | 0.000 |
Why?
|
| Ciliary Body | 1 | 1984 | 168 | 0.000 |
Why?
|
| Cell Count | 1 | 1987 | 1823 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 3 | 1989 | 22331 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 13024 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1985 | 565 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1982 | 339 | 0.000 |
Why?
|
| Esophagus | 1 | 1988 | 1037 | 0.000 |
Why?
|
| Intestine, Large | 1 | 1981 | 69 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1982 | 287 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 1930 | 0.000 |
Why?
|
| Models, Neurological | 1 | 1990 | 1747 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1770 | 0.000 |
Why?
|
| Choroid | 1 | 1984 | 363 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1985 | 1134 | 0.000 |
Why?
|
| Culture Media | 1 | 1983 | 890 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1983 | 405 | 0.000 |
Why?
|
| Cell Communication | 1 | 1988 | 1660 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 993 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1984 | 1263 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 588 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 755 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1986 | 1113 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 860 | 0.000 |
Why?
|
| Thalamus | 1 | 1987 | 1048 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15839 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1985 | 1774 | 0.000 |
Why?
|
| Intestines | 1 | 1988 | 1906 | 0.000 |
Why?
|
| Biopolymers | 1 | 1979 | 181 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1979 | 655 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3807 | 0.000 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1978 | 40 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1986 | 1865 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1990 | 2060 | 0.000 |
Why?
|
| Solubility | 1 | 1979 | 1078 | 0.000 |
Why?
|
| Disulfides | 1 | 1979 | 462 | 0.000 |
Why?
|
| Cell Survival | 1 | 1987 | 5746 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1974 | 18294 | 0.000 |
Why?
|
| Medulloblastoma | 1 | 1980 | 658 | 0.000 |
Why?
|
| Temperature | 1 | 1979 | 2226 | 0.000 |
Why?
|
| Adolescent | 3 | 1984 | 88832 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 9296 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1984 | 11888 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1980 | 3459 | 0.000 |
Why?
|
| Macrophages | 1 | 1977 | 5772 | 0.000 |
Why?
|